Ignite Creation Date:
2024-05-06 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03663335
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2018-06-04
Brief Title:
Study of Efficacy Safety Tolerability Pharmacokinetic PK and Pharmacodynamic PD of an Anti-CD40 Monoclonal Antibody CFZ533 in Kidney Transplant Recipients
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Kidney Transplant Rejection |
Keywords:
| Name | View |
|---|---|
| Renal transplantation CFZ533 CNI-free immunosuppression transplant rejection allograft rejection | View |